AI Prospecting for Amgen
Company data:
Company size:
28000 employeesWebsite URL:
https://www.amgen.comIndustry
BiotechnologyHeadquarters:
Thousand Oaks, California, USAInvestment round:
NASDAQ: AMGNARR:
$26 billionKey stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about Amgen
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Amgen announced that IMDELLTRA® (tarlatamab-dlle) demonstrated superior overall survival in patients with small cell lung cancer who progressed on or after a single line of platinum-based chemotherapy, meeting the primary endpoint in the global Phase 3 DeLLphi-304 clinical trial[1].
Amgen announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) as the first and only treatment for IgG4-related disease, following the Phase III MITIGATE trial which showed an 87% reduction in disease flares versus placebo[3][5].
Amgen's KRAS blocker Lumakras received FDA approval for use in colorectal cancer, based on progression-free survival findings from the Phase III CodeBreaK 300 trial, which showed significant improvement when Lumakras was combined with Vectibix[4].
Open job positions at Amgen
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Specialty Account Manager - TEPEZZA (Endocrinology) - New Orleans, LA
Data Solution Architect (Data Engineering)
Data Engineer
